Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK1 | P04183 | 5/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | ALB | P02768 | 1/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.49 |
| ▸ | BLM | P54132 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| 4'-Thiothymidine SCHEMBL6266871 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL3517583 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL13083838 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL23897578 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL6311407 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL23897630 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL3517588 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL9520953 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL12642446 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB | |
| 4'-Thiothymidine SCHEMBL30381070 | 1.00 | TK1 (0.49) | TK1ALDH1A1LMNAALBPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 74 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2331106-B1 | NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS | IMP INNOVATIONS LTD (GB) | 2012-10-10 | — | — | EP | claimed |
| US-20110236312-A1 | NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2011-09-29 | — | — | US | claimed |
| EP-2331106-A1 | NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS | Imperial Innovations Limited (GB) | 2011-06-15 | — | — | EP | claimed |
| WO-2010023457-A1 | NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS | IMPERIAL INNOVATIONS LIMITED (GB) | 2010-03-04 | — | — | WO | claimed |
| US-5591722-A | ANTICANCER AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1997-01-07 | — | — | US | claimed |
| EP-0491793-A4 | 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS | — | 1993-03-03 | — | — | EP | claimed |
| EP-0491793-A1 | 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1992-07-01 | — | — | EP | claimed |
| WO-1991004033-A1 | 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1991-04-04 | — | — | WO | claimed |
| EP-3680334-B1 | DOUBLE-STRANDED RNA MOLECULE TARGETING CKIP-1 AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO LTD (CN) | 2026-03-25 | — | — | EP | disclosed |
| EP-4713477-A1 | DETECTION OF TARGET ANALYTES USING MULTIMODAL SIGNAL PROBES | Roche Molecular Systems, Inc. (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20250354201-A1 | FERROCENE LABELLED PRIMERS FOR ELECTROCHEMICAL DETECTION | ROCHE MOLECULAR SYSTEMS INC (US) | 2025-11-20 | — | — | US | disclosed |
| EP-4536852-A1 | FERROCENE LABELLED PRIMERS FOR ELECTROCHEMICAL DETECTION | F. Hoffmann-La Roche AG (CH) | 2025-04-16 | — | — | EP | disclosed |
| CN-119343463-A | Ferrocene-labeled primers for electrochemical detection | 豪夫迈·罗氏有限公司 | 2025-01-21 | — | — | CN | disclosed |
| WO-2024235904-A1 | DETECTION OF TARGET ANALYTES USING MULTIMODAL SIGNAL PROBES | ROCHE MOLECULAR SYSTEMS, INC. (US) | 2024-11-21 | — | — | WO | disclosed |
| US-5478928-A | Useful as antiviral agents in the treatment and prevention of AIDS | SOUTHERN RESEARCH INSTITUTE (US) | 1995-12-26 | — | — | US | disclosed |
| WO-1993016095-A1 | OLIGOTHIONUCLEOTIDES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 1993-08-19 | — | — | WO | disclosed |
| EP-0491793-A4 | 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS | — | 1993-03-03 | — | — | EP | disclosed |
| US-5128458-A | 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents | SOUTHERN RESEARCH INSTITUTE (US) | 1992-07-07 | — | — | US | disclosed |
| EP-0491793-A1 | 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1992-07-01 | — | — | EP | disclosed |
| WO-1991004033-A1 | 2'-DEOXY-4'-THIORIBONUCLEOSIDES AS ANTIVIRAL AND ANTICANCER AGENTS | SOUTHERN RESEARCH INSTITUTE (US) | 1991-04-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110236312-A1 | NUCLEOSIDE ANALOGUES USEFUL AS POSITRON EMISSION TOMOGRAPHY (PET) IMAGING AGENTS | TYMP, SLC29A1, NT5C3B | TK1 16/4885ALDH1A1 2290/4885LMNA 3864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.